Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

1,056 total articles

Itron: Buy the Q4 Beat, Back the M&A-Led Growth Run

Itron: Buy the Q4 Beat, Back the M&A-Led Growth Run

Itron's recent operational momentum, strategic tuck-ins (Urbint and Locusview) and exposure to a growing smart-utilities market give the stock a favorable risk/reward. Valuation metrics (P/E ~15, EV/EBITDA ~12) and robust free cash flow underpin a swing trade setup with defined entry, stop and target levels.

Why TSLA Is Re-accelerating: Upgrade to Buy

Why TSLA Is Re-accelerating: Upgrade to Buy

Tesla looks past the carnage of 2025 and is showing signs of a sustained comeback: positive free cash flow of $6.22B, a market cap near $1.56T and technical momentum combine with a large battery storage TAM to justify a tactical upgrade. This trade plan targets $480 with a $375 stop for a mid-term push tied to improving fundamentals and several nea…

Snap MAU Momentum: A Reasonable Long Trade From the Lows

Snap MAU Momentum: A Reasonable Long Trade From the Lows

Snap reported 946 million monthly active users and beat Q4 estimates with $1.72B revenue. The shares are trading near a 52-week low while free cash flow and revenue growth provide a tangible path to multiple expansion. We lay out a long trade with entry, stop and target and the catalysts and risks that matter.

Pfizer Bounce: High Yield and Cheap Multiple Set Up a Mid-Term Long

Pfizer Bounce: High Yield and Cheap Multiple Set Up a Mid-Term Long

Pfizer is offering a beaten-down valuation, a 6%+ yield, and improving clinical momentum. The stock looks attractive for a mid-term swing trade: entry near current levels, stop below the support band, target at a multiple re-rating if product wins and pipeline readouts continue to surprise. This is a trade, not a deep-value buy-and-hold call; risk …

IREN Setup: Buy the Re-rate Ahead of Massive ARR Recognition

IREN Setup: Buy the Re-rate Ahead of Massive ARR Recognition

IREN is sitting at a crossroads: the stock is volatile after a weak quarter, but the company has secured financing, a confirmed large hyperscaler contract, and accelerating GPU capacity that should transform revenue mix from crypto to recurring AI cloud sales. This trade targets a re-rate as ARR ramps and institutional demand increases around index…

Smith & Wesson - Relocation Done, Cash Flow Back: A Tactical Long

Smith & Wesson - Relocation Done, Cash Flow Back: A Tactical Long

Smith & Wesson (SWBI) has finished its relocation and is generating positive free cash flow again. At a market cap near $527M and free cash flow of $21.3M, the stock looks reasonably supported despite a high P/E. This trade idea targets $15.50 over a 180-trading-day horizon with a tight structural stop at $10.80 to limit downside if margins deterio…

IREN: Buy the GPU Transition After the Q2 Capitulation

IREN: Buy the GPU Transition After the Q2 Capitulation

IREN has swung from crypto-dependent volatility toward an AI infrastructure identity. Recent financing, a large Microsoft contract and a 1.4 GW facility coming online give the stock a tangible re-rating path. The trade: a long entry at current levels with a defined stop and target to ride a mid-to-long-term re-rating while respecting execution risk…

Freshworks: The SaaSpocalypse Panic Has Created a Tactical Long Setup

Freshworks: The SaaSpocalypse Panic Has Created a Tactical Long Setup

Freshworks (FRSH) sold off sharply after conservative guidance, but the company still generates meaningful free cash flow, has double-digit revenue growth, and trades at a reasonable multiple to FCF and sales. With RSI in deeply oversold territory and short interest elevated, this is a tactical long for traders who want a defined-risk exposure to a…

Buy the Dip in Cognizant: Add on Oversold Momentum and Cheap Cash Flow

Buy the Dip in Cognizant: Add on Oversold Momentum and Cheap Cash Flow

Cognizant (CTSH) is a beaten-down leader in IT services that is oversold technically and cheap on cash-flow metrics. The business still throws off roughly $2.6B in free cash flow and trades at ~14x earnings and ~12x free cash flow. With AI/cloud-led outsourcing demand and industry-specific momentum in insurance and healthcare, this is a tactical bu…